HIFU System

Sonablate is an FDA-approved focal HIFU (High-Intensity Focused Ultrasound) system that is successfully used for the precise ablation of targeted tissue areas at varying depths. Thanks to its advanced Biplane HIFU probe, the system enables accurate treatment of focal regions while continuously monitoring each ablation in real time.

With the validated TCM (Tissue Change Monitoring) feature, the system provides a high level of safety by confirming whether sufficient energy has been delivered to the target tissue or if additional energy is required. This real-time feedback ensures controlled, effective, and safe treatment throughout the procedure.

Proven Clinical Experience and Long-Term Data

The Sonablate system has been used in more than 2,000 registered cases, with clinical data available for follow-up periods of up to 14 years. These multicenter studies are conducted under the leadership of Professor Mark Emberton, providing strong scientific evidence and long-term reliability for the technology.

Minimally Invasive and Robotic Precision

The Sonablate HIFU system is a minimally invasive robotic device that delivers highly focused ablative energy using advanced ultrasound technology. During the procedure, the Sonablate probe is positioned relative to the patient’s rectum, allowing the physician to precisely map and customize the ablation plan.

HIFU treatment is performed by creating controlled, localized lesions—often described as “rice grain–sized” focal points—ensuring targeted tissue destruction while preserving surrounding healthy structures.